Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916

ISSN (Print): 0972-8988


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License

( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Review (Published online: 14-11-2014)

10. Current practices and research updates on diabetes mellitus in canine - Pankaj Kumar, Rashmi Rekha Kumari, Manish Kumar, Sanjiv Kumar and Asit Chakrabarti

Veterinary World, 7(11): 952-959



   doi: 10.14202/vetworld.2014.952-959



Pankaj Kumar: Division of Livestock and Fisheries Management, ICAR Research Complex for Eastern Region, Patna, Bihar, India;

Rashmi Rekha Kumari: Department of Pharmacology, Bihar Veterinary College, Patna, Bihar, India;

Manish Kumar: Department of Biotechnology, Indian Institute of Technology Guwahati, Assam, India;

Sanjiv Kumar: Department of Pathology, Bihar Veterinary College, Patna, Bihar, India;

Asit Chakrabarti: Division of Livestock and Fisheries Management, ICAR Research Complex for Eastern Region, Patna, Bihar, India;


Received: 31-07-2014, Revised: 05-10-2014, Accepted: 09-10-2014, Published online: 14-11-2014


Corresponding author: Pankaj Kumar, e-mail:

Diabetes has evidence in ancient literatures, though recently is being considered as one amongst the most emerging disease condition in both human and companion animals. Diabetes mellitus is one of the common endocrinopathy of dog characterized by hyperglycemia, glycosuria and weight loss. Reports suggests high fraction of canine population suffer with diabetes world over. Studies in different veterinary hospitals of United States suggest increase in cases of canine diabetes and decrease in case fatality rate over time. Increase in cases of canine diabetes worldwide is attributed to awareness amongst pet owners, better veterinary health facilities, breed preferences by dog owners, increase dependence on commercial feeds, obesity, etc. Diabetes in most dogs is immune mediated and insulin dependent. Breed predisposition in canine is attributed to dog leukocyte antigen gene pool encoding form major histocompatibility complex-II molecules, however research is still underway. Diagnosis of diabetes still relies on blood sugar evaluation for screening of canine population, though many other diagnostic methods have shown promising benefits including measurement of fructosamine and glycated haemoglobin. Management of diabetes in dog is based on insulin therapy, diet modification and exercise. Use of oral anti-diabetics drugs in canine is limited though experimental studies have shown promising results. Alternative therapies have been explored, but only a few approaches have shown promise for clinical application.

Keywords: canine, diabetes mellitus, emergence, fructosamine, glycated haemoglobin, insulin, streptozotocin.

1. Abdullah, N., Attia, J., Oldmeadow, C., Scott, R.J. and Holliday, E.J. (2014) The architecture of risk for type 2 diabetes: Understanding Asia in the context of global findings. Int. J. Endocrin., 2014: 21.
PMid:24744783 PMCid:PMC3976842
2. Jeong, Y.W., Lee, G.S., Kim, J.J., Park, S.W., Ko, K.H., Kang, M., Kim, Y.K., Jung, E.M., Hyun, S.H., Shin, T., Jeung, E.B. and Hwang, W.S. (2012) Establishment of a canine model of human type 2 diabetes mellitus by overexpressing phosphoenolypyruvate carboxykinase. Int. J. Mol. Med., 30(2): 321-329.
3. Ripoll, B.C. and Leutholtz, I. (2011) Exercise and Disease Management. 2nd ed. CRC Press, Boca Raton. p25.
4. Zajac, J., Shrestha, A., Patel, P. and Poretsky, L. (2010) The main events in the history of diabetes mellitus. In: Principles of Diabetes Mellitus, Springer, US. p3-16.
5. Major, R.M. (1932) Classic Description of Disease. 2nd ed. Charles C Thomas, Springfield.
PMid:16994366 PMCid:PMC1394657
6. Das, A.K. and Shah, S. (2011) History of diabetes: From ants to analogs. J. Assoc. Physician India, 59: 6-7.
7. Gardiner, A. (2006) The history of canine diabetes part 1: Diabetes in animals before insulin. Vet. Times, 36: 10-11.
8. De Leiva-Hidalgo, A., Brugučs-Brugučs, E., and de Leiva-Pérez, A. (2011) From pancreatic extracts to artificial pancreas: History, science and controversies about the discovery of the pancreatic antidiabetic hormone. VII: Early clinical use of pancreatic extracts (1921-1923). Adv. Diabetol., 27: 15-26.
9. Sakata, N., Yoshimatsu, G., Tsuchiya, H., Egawa, S. and Unno, M. (2012) Animal models of diabetes for islet transplantation. J. Exp. Diabetes. Res., 2012: 11.
PMid:23346100 PMCid:PMC3546491
10. Nerup, J., Platz, P., Andersen, O.O., Christy, M., Lyngsoe, J., Poulsen, J.E., Ryder, L.P., Nielsen, L.S., Thomsen, M. and Svejgaard, A. (1974) HLA antigens and diabetes mellitus. Lancet, 2: 864-866.
11. Rees, D.A. and Alcolado, J. C. (2005) Animal models of diabetes mellitus. Diabetes Med., 22: 359-370.
12. Islam, M.S. and Loots, du T. (2009) Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin., 31(4): 249-261.
13. Chatzigeorgiou, A., Halapas, A., Kalafatakis, K., and Kamper, E. (2009). The use of animal models in the study of diabetes mellitus. In Vivo, 23(2): 245-258.
14. Etuk, E.U. (2010) Animals models for studying diabetes mellitus. Agric. Biol. J. North Am., 1: 130-134.
15. King, A.J. (2012) The use of animal models in diabetes research. Br. J. Pharmacol., 166: 877-894.
PMid:22352879 PMCid:PMC3417415
16. Eddouks, M., Chattopadhyay, D. and Zeggwagh, N.A. (2012) Animal models as tools to investigate antidiabetic and anti-inflammatory plants. J. Evid. Based Complement. Alternat, Med., 2012: 142087.
PMid:22899950 PMCid:PMC3414199
17. Lenzen, S. (2008) The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51(2): 216-226.
18. Etuk, E.U. and Muhammed, B.J. (2010) Evidence based analysis of chemical method of induction of diabetes mellitus in experimental rats. Int. J. Pharm. Sci., 1: 139-142.
19. Yamagami, T., Miwa, A., Takasawa, S. and Yamamoto, H. (1985) Introduction of rats pancreatic -β-cell tumour by the combined administration of streptozotocin or alloxan and poly (adenosine diphosphate ribose) synthetase inhibitors. Cancer Res., 45(4): 1845-1849.
20. Feldman, E.C. and Nelson, R.W. (1996) Canine and Feline Endocrinology and Reproduction. 2nd ed. W. B. Saunders, Philadelphia, PA.
21. Catchpole, B., Kennedy, L.J., Davisony, L.J. and Ollier, W.E.R. (2008) Canine diabetes mellitus: From phenotype to genotype. J. Small Anim. Pract., 49(1): 4-10.
22. Montgomery, T.M., Nelson, R.W., Feldman, E.C., Robertson, K. and Polonsky, K.S. (1996) Basal and glucagon-stimulated plasma C peptide concentrations in healthy dogs, dogs with diabetes mellitus and dogs with hyperadrenocorticism. J. Vet. Intern. Med., 10(3): 116-122.
23. Davison, L.J., Walding, B., Herrtage, M.E. and Catchpole, B. (2008) Anti‐Insulin antibodies in diabetic dogs before and after treatment with different insulin preparations. J. Vet. Intern. Med., 22(6): 1317-1325.
24. Rand, J.S., Fleeman, L.M., Farrow, H.A., Appleton, D.J. and Lederer, R. (2004) Canine and feline diabetes mellitus: nature or nurture? J. Nutr., 134 8 Suppl: 2072S-2080S.
25. Fall, T., Kreuger, S.J., Juberget, Ĺ., Bergström, A. and Hedhammar, Ĺ. (2008) Gestational diabetes mellitus in 13 dogs. J. Vet. Intern. Med., 22(6): 1296-1300.
26. Concannon, P.W. (1986) Canine pregnancy and parturition. Vet. Clin. North Am. Small, 16(3): 453-475.
27. Kim, Ah.Y., Kang, J.H. and Yang, M.P. (2012) Transient diestrus-related diabetes mellitus in a dog. J. Biomed. Res., 13: 265-267.
28. Mared, M., Catchpole, B., Kampe, O. and Fall, T. (2012) Evaluation of circulating concentrations of glucose homeostasis biomarkers, progesterone, and growth hormone in healthy Elkhounds during anestrus and diestrus. Am. J. Vet. Res., 73: 242-247.
29. Neiger, R., Jaunin, V.B. and Boujon, C.E. (1996) Exocrine pancreatic insufficiency combined with insulin‐dependent diabetes mellitus in a juvenile German shepherd dog. J. Small Anim. Pract., 37: 344-349.
30. Caney, S. (2013) Pancreatitis and diabetes in cats. Vet. Clin. North Am. Small., 43(2): 303-317.
31. Anonymous. (2011) Diabetes mellitus. In: Banfield Pet Hospital® State of Pet Health 2011 Report. Vol. 1. p12.
32. Catchpole, B., Ristic, J.M., Fleeman, L.M. and Davison, L.J. (2005) Canine diabetes mellitus: can old dogs teach us new tricks? Diabetologia, 48(10): 1948-1956.
33. McCann, T.M., Simpson, K.E., Shaw, D.J., Butt, J.A. and Gunn-Moore, D.A. (2007) feline diabetes mellitus in the UK: The prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J. Feline. Med. Surg., 9(4): 289-299.
34. Guptill, L., Glickman, L. and Glickman, N. (2003) Time trends and risk factors for diabetes mellitus in dogs: Analysis of veterinary medical data base records (1970-1999). Vet. J., 165(3): 240-247.
35. Anonymous. (2012) Management of chronic pancreatic disorders with special reference to diabetes mellitus in dogs. In: Annual Report of Indian Veterinary Research Institute, Izatnagar. p56.
36. Catchpole, B., Adams, J.P., Holdera, A. L., Shortc, A.D., Ollierc, W.E.R. and Kennedyc, L.J. (2013) Genetics of canine diabetes mellitus: Are the diabetes susceptibility genes identified in humans involved in breed susceptibility to diabetes mellitus in dogs? Vet. J., 195(2): 139-147.
37. Hess, R.S. (2010) Insulin resistance in dogs. Vet. Clin. North Am. Small, 40(2): 309-316.
38. Kawasumi, K., Kashiwado, N., Okada, Y., Sawamura, M., Sasaki, Y., Iwazaki, E., Mori, N., Yamamoto, I. and Arai, T. (2014) Age effects on plasma cholesterol and triglyceride profiles and metabolite concentrations in dogs. BMC Vet. Res., 10: 57.
PMid:24597741 PMCid:PMC3946593
39. Alejandro, R., Feldman, E.C., Shienvold, F.L. and Mintz, D.H. (1988) Advances in canine diabetes mellitus research: Etiopathology and results of islet transplantation. J. Am. Vet. Med. Assoc., 193(9): 1050-1055.
40. Verkest, K.R., Fleeman, L.M., Morton, J.M., Groen, S.J., Suchodolski, J.S., Steiner, J. M. and Rand, J.S. (2012) Association of postprandial serum triglyceride concentration and serum canine pancreatic lipase immunoreactivity in overweight and obese dogs. J. Vet. Intern. Med., 26: 46-53.
41. Blois, S.L., Dickie, E., Kruth, S.A. and Allen, D.G. (2011) Multiple endocrine diseases in dogs: 35 cases (1996-2009). J. Am. Vet. Med. Assoc., 238(12): 1616-1621.
42. Atkins, C.E. and MacDonald, M.J. (1987) Canine diabetes mellitus has a seasonal incidence: Implications relevant to human diabetes. Diabetes Res., 5(2): 83-87.
43. Lem, K.Y., Fosgate, G.T., Norby, B. and Steiner, J.M. (2008) Associations between dietary factors and pancreatitis in dogs. J. Am. Vet. Med. Assoc., 233(9): 1425-1431.
44. Klinkenberg, H., Sallander, M.H. and Hedhammar, Ĺ. (2006) Feeding, exercise, and weight identified as risk factors in canine diabetes mellitus. J. Nutr., 136 7 Suppl: 1985S-1987S.
45. Durocher, L.L., Hinchcliff, K.W., DiBartola, S.P. and Johnson, S.E. (2008) Acid-base and hormonal abnormalities in dogs with naturally occurring diabetes mellitus. J. Am. Vet. Med. Assoc., 232(9): 1310-1320.
46. Hjärre, A. (1910) Sections befund beim diabetes mellitus beim rind. Berl. Munch. Tierarztl. Wochenschr., 26: 389-390.
47. Beam, S., Correa, M.T. and Davidson, M.G. (1999) A retrospective-cohort study on the development of cataracts in dogs with diabetes mellitus: 200 cases. Vet. Ophthalmol., 2(3): 169-172.
48. Comazzi, S., Bertazzolo, W., Bonfanti, U., Spagnolo, V. and Sartorelli, P. (2008) Advanced glycation end products and sorbitol in blood from differently compensated diabetic dogs. Res. Vet. Sci., 84(3): 341-346.
49. Basher, A.W. and Roberts, S.M. (1995) Ocular manifestations of diabetes mellitus: Diabetic cataracts in dogs. Vet. Clin. North. Am. Small., 25(3): 661-676.
50. Wilkie, D.A., Gemensky‐Metzler, A.J., Colitz, C.M.H., Bras, I.D., Kuonen, V.J., Norris, K.N. and Basham, C.R. (2006) Canine cataracts, diabetes mellitus and spontaneous lens capsule rupture: a retrospective study of 18 dogs. Vet. Ophthalmol., 9: 328-334.
51. Fleeman, L.M. and Rand, J.S. (2008) Diabetes mellitus: Nutritional strategies. In: Pibot, P., Biourge, V. and Elliott, D.A., editors. Encyclopedia of Canine Clinical Nutrition. International Veterinary Information Service, Ithaca, NY. A4206.0308. Available from: [Updated on 31 Mar 2008].
52. Johnson, C.A. (2008). Glucose homeostasis during canine pregnancy: Insulin resistance, ketosis, and hypoglycemia. Theriogenology, 70: 1418-1423.
53. Bruyette, D. (2013) The Pancreas. The Merck Veterinary Manual. 8th ed. Merck Sharp & Dohme Corp., USA.
54. Palmer, J.P., Fleming, G.A., Greenbaum, C.J., Herold, K.C., Jansa, L.D., Kolb, H. and Steffes, M.W. (2004) C-Peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function report of an ADA workshop. Diabetes, 53(1): 250-264.
55. Jensen, A.L. (1995) Glycated blood proteins in canine diabetes mellitus. Vet. Rec., 137(16): 401-405.
56. Haberer, B. and Reusch, C.E. (1998) Glycated haemoglobin in various pathological conditions: investigations based on a new, fully automated method. J. Small Anim. Pract., 39(11): 510-517.
57. Reusch, C.E., Liehs, M.R., Hoyer, M. and Vochezer, R. (1993) Fructosamine. A new parameter for diagnosis and metabolic control in diabetic dogs and cats. J. Vet. Intern. Med., 7(3): 177-182.
58. Briggs, C.E., Nelson, R.W., Feldman, E.C., Elliott, D.A. and Neal, L.A. (2000) Reliability of history and physical examination findings for assessing control of glycemia in dogs with diabetes mellitus: 53 cases (1995-1998). J. Am. Vet. Med. Assoc., 217(1): 48-53.
59. Sako, T., Mori, A., Lee, P., Takahashi, T., Izawa, T., Karasawa, S., Furuuchi, M., Azakami, D., Mizukoshi, M., Mizutani, H., Kiyosawa, Y. and Arai, T. (2008) Diagnostic significance of serum glycated albumin in diabetic dogs. J. Vet. Diagn. Invest., 20(5): 634-638.
60. Steiner, J.M., Lees, G.E., Willard, M.D., Teague, S.R. and Williams, D.A. (2003) Serum canine pancreatic lipase immunoreactivity (cPLI) concentration is not altered by oral prednisone (abstract). J. Vet. Intern. Med., 17: 44.
61. Davison, L.J., Podd, S.L., Ristic, J.M., Herrtage, M.E., Parnham, A. and Catchpole, B. (2002) Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs. J. Small Anim. Pract., 43(12):526-532.
62. Davison, L.J., Herrtage, M.E., Steiner, J.M., Williams, D.A. and Catchpole, B. (2003) Evidence of anti-insulin autoreactivity and pancreatic inflammation in newly-diagnosed diabetic dogs (abstract). J. Vet. Intern. Med., 17: 395.
63. Monroe, W.E., Laxton, D., Fallin, E.A., Richter, K.P., Santen, D.R., Panciera, D.L., Todd, L.T., Kimberly, A.W., John, R.H., Steve, H., Mark, R.F. and Shinn, J.S. (2005) Efficacy and safety of a purified porcine insulin zinc suspension for managing diabetes mellitus in dogs. J. Vet. Intern. Med., 19: 675-682.
64. Rucinsky, R., Cook, A., Haley, S., Nelson, R., Zoran, D.L. and Poundstone, M. (2010) AAHA diabetes management guidelines for dogs and cats. J. Am. Anim. Hosp. Assoc., 46(3): 215-224.
65. Maggiore, A.D., Nelson, R.W., Dennis, J., Johnson, E. and Kass, P.H. (2012) Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus. J. Vet. Intern. Med., 26(1): 109-115.
66. Fernoaga, C., Codreanu, M. and Cornila, M. (2009) The use of lantus insulin in diabetes mellitus type I in dogs and cats. Sci. Vet. Med., XLII: 224-228.
67. Hess, R.S., Kass, P.H. and Ward, C.R. (2000). Breed distribution of dogs with diabetes mellitus admitted to a tertiary care facility. J. Am. Vet. Med. Assoc., 216(9): 1414-1417.
68. Nelson, R.W. (2000) Oral medications for treating diabetes mellitus in dogs and cats. J. Small Anim. Pract., 41(11): 486-490.
69. Ballagi-Pordány, G., Koltai, MZ, Aranyi. Z. and Pogátsa, G. (1991) Direct effect of hypoglycemic sulphonylureas on the cardiovascular system of dogs. Diabetes Res. Clin. Pract., 11(1): 47-52.
70. Mark, M. and Grell, W. (1997) Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs. Br. J. Pharmacol., 121: 1597-1604.
PMid:9283692 PMCid:PMC1564864
71. Geisen, K. (1988) Special pharmacology of the new sulfonylurea glimepiride. Arzneim. Forsch. Drug Res., 38: 1120-1130.
72. Rundles, W.R. and Swan, H. (1957) Islet cell transplantation. Surg. Forum, 7: 502-506.
73. Scharp, D.W. and Marchetti, P. (2014) Encapsulated islets for diabetes therapy: History, current progress, and critical issues requiring solution. Adv. Drug. Deliv. Rev., 67-68: 35-73.
74. Prochorov, A.V., Tretjak, S.I., Goranov, V.A., Glinnik, A.A. and Goltsev, M.V. (2008) Treatment of insulin dependent diabetes mellitus with intravascular transplantation of pancreatic islet cells without immunosuppressive therapy. Adv. Med. Sci., 53: 240-244.
75. Sun, A.M., O'Shea, G.M. and Goosen. M.F.A. (1984) Injectable microencapsulated islet cells as a bioartificial pancreas. Appl. Biochem. Biotechnol., 10: 87-99.
76. Weber, C.J., Zabinski, S., Koschitzky, T., Wicker, L., Rajotte, R., D'Agati, V., Peterson, L., Norton, J. and Reemtsma, K. (1990) The role of CD4+ helper T cells in the destruction of microencapsulated islets xenografts in NOD mice. Transplantation, 49(2): 396-404.
77. Callejas, D., Mann, C.J., Ayuso, E., Lage, R., Grifoll, I., Roca, C., Andaluz, A., Ruiz-de Gopegui, R., Montané, J., Mu-oz, S., Ferre, T., Haurigot, V., Zhou, S., Ruberte, J., Mingozzi, F., High, K.A., Garcia, F. and Bosch, F. (2013) Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy. Diabetes, 62(5): 1718-1729.
PMid:23378612 PMCid:PMC3636629
78. Mas, A., Montane, J., Anguela, X.M., Munoz, S., Douar, A.M., Riu, E., Otaegui, P. and Bosch, F. (2006). Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes, 55(6): 1546-1553.